Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neratinib + Trastuzumab in Advanced HER2+ Breast Cancer
NCT00398567Phase 2Completed
- Sponsor
- Puma Biotechnology, Inc.
- Start
- Apr 2007
- Primary completion
- Jul 2009
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of neratinib in breast cancer, sponsored by Puma Biotechnology, Inc.. Started Apr 2007; status: completed.
02
Drugs
neratinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00398567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398567.